Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a Tertiary care hospital
JPMA-Journal of Pakistan Medical Association. 2004; 54 (1): 17-20
Dans Anglais
| IMEMR
| ID: emr-175582
ABSTRACT
Objective:
To evaluate the response of Imatinib mesylate in patients with myeloid leukemia in chronic, accelerated and blast phase
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
J. Pak. Med. Assoc.
Année:
2004
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS